AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S.

NEWBURYPORT, MA, UNITED STATES, September 23, 2024 /EINPresswire.com/ — AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, is pleased to announce today the execution of a co-marketing agreement to co-promote in the USA Next Generation Sequencing (“NGS”) solutions combining AdvancedDx Biological Laboratories USA Inc ’ DeepChek^® assays and software with Complete Genomics‘ DNBSEQ™ genetic sequencing platforms to all microbiology laboratories in the USA.

Having the possibility to offer NGS-based end-to-end solutions will help microbiology laboratories to get equipped with robust and innovative assays, sequencing systems and downstream analysis software available for many applications including but not restricted to HIV, viral hepatitis (HBV/HCV/HDV), respiratory viruses (Influenza, SARS-CoV-2, RSV…), CMV, HSV, BKV, Tuberculosis.

“We are thrilled to join forces and be in a position to offer end-to-end solutions based on the most advanced sequencing technologies, to all laboratories in the USA, involved in microbiology genotyping, These products are part of the NGS market was estimated at USD 1.42 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 13.16% from 2023 to 2030,” said Dimitri Gonzalez, Head of Diagnostics at ABL Diagnostics.

“Complete Genomics is pleased to partner with ABL to offer microbiology laboratories a diverse menu of NGS-based infectious disease assays, developed on our low throughput sequencing platforms including the DNBSEQ-E25 and DNBSEQ-G99, with unparalleled speed, portability, ease of use and cost advantage,” said Radoje Drmanac, Founder and Chief Scientific Officer at Complete Genomics.

The detailed terms of the agreement have not been disclosed.

This press release was originally written and published by ABLD. The original announcement can be found here.

Media Contacts: 

Betsy Yates
Complete Genomics
> Contact

Chalom Sayada
ABL Diagnostics
[email protected]